Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) - Business Wire
- Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) Business Wire
- First COVID-19 vaccine tested in US poised for final testing WPVI-TV
- Experimental COVID-19 vaccine safe, generates immune response Medical Xpress
- Moderna Says Coronavirus Vaccine Trial Produced ‘Robust' Immune Response NBC 5 Dallas-Fort Worth
- U.S. COVID-19 vaccine program to start manufacturing by late summer, says U.S. official Reuters
- View Full Coverage on Google News